Marseille-Kliniken AG

EANS-Adhoc: - Marseille-Kliniken Group completes disposing of its rehabilitation division

  ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.

Disposing of rehabilitation division completed


Berlin, 30 April 2010. Marseille-Kliniken Group (Prime Standard, ISIN DE 0007783003, MKA) has completed the announced sale of its rehabilitation division.

The transaction includes the rehabilitation clinics operated by Karlsruher Sanatorium AG, a subsidiary of Marseille-Kliniken AG as well as rehabilitation clinic companies, directly held by Marseille-Kliniken AG. The buyer is a joint venture between the funds consulted by financial investor AUCTUS Capital Partners AG and the existing management team of the clinics.

End of ad hoc release

end of announcement                               euro adhoc

Further inquiry note:

Hillermann Consulting
Christian Hillermann
Investor Relations for Marseille-Kliniken AG
Poststraße 14/16
20354 Hamburg
Tel.: +49-(0)40 / 320 279-10
Fax: +49-(0)40 / 320 279-114

Marseille-Kliniken AG
Dr. Ute Buchheim
Friedrich-Ebert-Str. 65
33330 Gütersloh
Tel.: +49-(0)5241 / 90 39-35
Fax: +49-(0)5241 / 90 39-39

Branche: Pharmaceuticals
ISIN: DE0007783003
WKN: 778300
Index: CDAX, Classic All Share, Prime All Share
Börsen: Frankfurt / regulated dealing/prime standard
Berlin / free trade
Stuttgart / free trade
Düsseldorf / free trade
Hamburg / regulated dealing

Original-Content von: Marseille-Kliniken AG, übermittelt durch news aktuell

Weitere Meldungen: Marseille-Kliniken AG

Das könnte Sie auch interessieren: